Ribavirin Enhances IFN-α Signalling and MxA Expression: A Novel Immune Modulation Mechanism during Treatment of HCV
File Type:
PDFItem Type:
Journal ArticleDate:
2011Citation:
Stevenson NJ, Murphy AG, Bourke NB, Keogh CA, Hegarty JE, O'Farrelly C, Ribavirin Enhances IFN-α Signalling and MxA Expression: A Novel Immune Modulation Mechanism during Treatment of HCV, PLoS One, 6, 11, 2011, e27866Download Item:
Abstract:
The nucleoside analogue Ribavirin significantly increases patient response to IFN-? treatment of HCV, by directly inhibiting viral replication. Recent studies indicate that Ribavirin also regulates immunity and we propose that Ribavirin enhances specific interferon sensitive gene (ISG) expression by amplifying the IFN-?-JAK/STAT pathway. We found that IFN-?-induced STAT1 and STAT3 phosphorylation was increased in hepatocytes co-treated with Ribavirin and IFN-?, compared to IFN-? alone. Ribavirin specifically enhanced IFN-? induced mRNA and protein of the anti-viral mediator MxA, which co-localised with HCV core protein. These novel findings indicate for the first time that Ribavirin, in addition to its viral incorporation, also enhances IFN-?-JAK/STAT signalling, leading to a novel MxA-mediated immuno-modulatory mechanism that may enhance IFN-? anti-viral activity against HCV.
Sponsor
Grant Number
Health Research Board (HRB)
Author's Homepage:
http://people.tcd.ie/stevennjhttp://people.tcd.ie/nbourke
http://people.tcd.ie/jhegarty
http://people.tcd.ie/ofarrecl
http://people.tcd.ie/keoghc4
Description:
PUBLISHEDType of material:
Journal ArticleCollections
Series/Report no:
PLoS One6
11
Availability:
Full text availableKeywords:
Immunology, Hepatitis C Virus (HCV)Subject (TCD):
Genes & Society , Immunology, Inflammation & InfectionMetadata
Show full item recordLicences: